Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by Jane101on Jun 27, 2022 2:48pm
159 Views
Post# 34785315

RE:RE:RE:RE:Enough on Trogarzo/Rukobia - Back to what matters - TH-1902

RE:RE:RE:RE:Enough on Trogarzo/Rukobia - Back to what matters - TH-1902well, there are a lot of short sellers who sit on stock message boards and try to set up expectations that a company cannot ever meet and then profit.  That is a very sneaky-snake thing that happens a lot of the time.  I am new to the story and trying to learn as much as possible, but from your super long messages, I am thinking you don't want the company to succeed...why else would you outline such a long list of things that investors like us would read and then expect to see, since we don't all have the experience of being a portfolio manager and covering hte company so long...

Just saying, while you think you are hleping, you may be setting everyone up for a massive fall...

Additionally a lot of companies like Fidelity ban their portoflio managers from commenting on stock boards because of the RISKS associated with the implied positioning and how it opens someone up to personl law suits

  


<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse